Structural diversity and biological activities of terpenoids derived from Tripterygium wilfordii Hook. f
- PMID: 40264893
- PMCID: PMC12012611
- DOI: 10.1039/d4ra09048a
Structural diversity and biological activities of terpenoids derived from Tripterygium wilfordii Hook. f
Abstract
Terpenoids, a heterogeneous group of natural products, have garnered considerable attention in the field of drug discovery. This is attributed to their vast diversity, intricate structural features, and extensive biological activities. Tripterygium wilfordii Hook. f., a traditional medicinal plant with widespread application in East Asia, is particularly enriched in terpenoids, which can be classified into sesquiterpenoids, diterpenoids, and triterpenoids. The present review provides a comprehensive elaboration of the chemical structures and biological activities of 217 terpenoids isolated from T. wilfordii. The purpose is to shed light on their potential in pharmacological research and to stimulate innovative drug discovery as well as clinical applications. These terpenoids display a broad spectrum of biological activities, such as antitumor, anti - inflammatory, immunosuppressive, and other therapeutic effects. Nevertheless, their clinical application is impeded by issues related to toxicity and poor bioavailability. Future research efforts should be concentrated on exploring effective strategies to alleviate toxicity and enhance drug delivery systems. In addition, in - depth investigation into the structure-activity relationships and the identification of new active constituents are crucial for the development of more potent and safer drugs. This review serves as an exhaustive reference for the discovery and development of novel drugs based on the natural active products of T. wilfordii, providing valuable insights and guidance for researchers in the relevant field.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
A novel strategy to enhance terpenoids production using cambial meristematic cells of Tripterygium wilfordii Hook. f.Plant Methods. 2019 Nov 7;15:129. doi: 10.1186/s13007-019-0513-x. eCollection 2019. Plant Methods. 2019. PMID: 31719835 Free PMC article.
-
Therapeutic potential of demethylzeylasteral, a triterpenoid of the genus Tripterygium wilfordii.Fitoterapia. 2022 Nov;163:105333. doi: 10.1016/j.fitote.2022.105333. Epub 2022 Oct 13. Fitoterapia. 2022. PMID: 36244595 Review.
-
Mechanism for the therapeutic effect of Tripterygium wilfordii Hook. f. preparations on IgA nephropathy.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 May 28;47(5):573-582. doi: 10.11817/j.issn.1672-7347.2022.210410. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35753727 Free PMC article. Chinese, English.
-
A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F.Front Pharmacol. 2018 Feb 14;9:104. doi: 10.3389/fphar.2018.00104. eCollection 2018. Front Pharmacol. 2018. PMID: 29491837 Free PMC article. Review.
-
Combining multidimensional chromatography-mass spectrometry and feature-based molecular networking methods for the systematic characterization of compounds in the supercritical fluid extract of Tripterygium wilfordii Hook F.Analyst. 2022 Dec 20;148(1):61-73. doi: 10.1039/d2an01471h. Analyst. 2022. PMID: 36441185
References
-
- Zhou J. Hu T. Liu Y. Tu L. Song Y. Lu Y. Zhang Y. Tong Y. Zhao Y. Su P. Wu X. Huang L. Gao W. Phytochemistry. 2021;190:112868. - PubMed
-
- Guo H. Wang Z. Xu L. Zhang H. Chang R. Chen A. Electrophoresis. 2019;40:547–554. - PubMed
-
- Noel P. Von Hoff D. D. Saluja A. K. Velagapudi M. Borazanci E. Han H. Trends Pharmacol. Sci. 2019;40:327–341. - PubMed
-
- Lim H. Y. Ong P. S. Wang L. Goel A. Ding L. Li-Ann Wong A. Ho P. C. Sethi G. Xiang X. Goh B. C. Cancer Lett. 2021;521:252–267. - PubMed
-
- Lv H. Jiang L. Zhu M. Li Y. Luo M. Jiang P. Tong S. Zhang H. Yan J. Fitoterapia. 2019;137:104190. - PubMed
Publication types
LinkOut - more resources
Full Text Sources